University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

Simple item page
dc.contributor.authorLindström, Ulf
dc.contributor.authorDi Giuseppe, Daniela
dc.contributor.authorDelcoigne, Bénédicte
dc.contributor.authorGlintborg, Bente
dc.contributor.authorMöller, Burkhard
dc.contributor.authorCiurea, Adrian
dc.contributor.authorPombo-Suarez, Manuel
dc.contributor.authorSanchez-Piedra, Carlos
dc.contributor.authorEklund, Kari
dc.contributor.authorRelas, Heikki
dc.contributor.authorGudbjornsson, Bjorn
dc.contributor.authorLove, Thorvardur Jon
dc.contributor.authorJones, Gareth T.
dc.contributor.authorCodreanu, Catalin
dc.contributor.authorIonescu, Ruxandra
dc.contributor.authorNekvindova, Lucie
dc.contributor.authorZávada, Jakub
dc.contributor.authorAtas, Nuh
dc.contributor.authorYolbas, Servet
dc.contributor.authorFagerli, Karen Minde
dc.contributor.authorMichelsen, Brigitte
dc.contributor.authorRotar
dc.contributor.authorTomšič, Matija
dc.contributor.authorIannone, Florenzo
dc.contributor.authorSantos, Maria Jose
dc.contributor.authorAvila-Ribeiro, Pedro
dc.contributor.authorØrnbjerg, Lykke Midtbøll
dc.contributor.authorØstergaard, Mikkel
dc.contributor.authorJacobsson, Lennart T.H.
dc.contributor.authorAskling, Johan
dc.contributor.authorNissen, Michael J.
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.date.accessioned2021-11-02T11:48:01Z
dc.date.available2021-11-02T11:48:01Z
dc.date.issued2021-11
dc.descriptionFunding This work was supported by Novartis. Novartis had no influence on the data collection, statistical analyses, manuscript preparation or decision to submit. The work was also supported by NordForsken
dc.description.statusPeer revieweden
dc.format.extent9
dc.format.extent2478106
dc.identifier199038215
dc.identifier446b675b-1f0f-45a2-aa34-6f47f79aed05
dc.identifier85107521561
dc.identifier34083206
dc.identifier000708996500024
dc.identifier.citationLindström, U, Di Giuseppe, D, Delcoigne, B, Glintborg, B, Möller, B, Ciurea, A, Pombo-Suarez, M, Sanchez-Piedra, C, Eklund, K, Relas, H, Gudbjornsson, B, Love, T J, Jones, G T, Codreanu, C, Ionescu, R, Nekvindova, L, Závada, J, Atas, N, Yolbas, S, Fagerli, K M, Michelsen, B, Rotar, Tomšič, M, Iannone, F, Santos, M J, Avila-Ribeiro, P, Ørnbjerg, L M, Østergaard, M, Jacobsson, L T H, Askling, J & Nissen, M J 2021, 'Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration', Annals of the Rheumatic Diseases, vol. 80, no. 11, 220097, pp. 1410-1418. https://doi.org/10.1136/annrheumdis-2021-220097en
dc.identifier.doi10.1136/annrheumdis-2021-220097
dc.identifier.iss11en
dc.identifier.issn0003-4967
dc.identifier.otherORCID: /0000-0003-0016-7591/work/99292748
dc.identifier.otherJisc: 48001c17edca4d99b98be99856efd709
dc.identifier.urihttps://hdl.handle.net/2164/17428
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85107521561&partnerID=8YFLogxKen
dc.identifier.vol80en
dc.language.isoeng
dc.relation.ispartofAnnals of the Rheumatic Diseasesen
dc.subjectarthritisen
dc.subjectmethotrexateen
dc.subjectpsoriaticen
dc.subjecttumour necrosis factor inhibitorsen
dc.subjectR Medicineen
dc.subjectRheumatologyen
dc.subjectImmunology and Allergyen
dc.subjectImmunologyen
dc.subjectGeneral Biochemistry,Genetics and Molecular Biologyen
dc.subjectSupplementary Informationen
dc.subjectSupplementary Dataen
dc.subject.lccRen
dc.titleEffectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaborationen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Lindstrom_etal_ES_Effectiveness_And_Treatment_VoR.pdf
Size:
2.36 MB
Format:
Adobe Portable Document Format
Download

Collections

All research